Oncology Institute (DFPH) Long-Term Investments (2020 - 2023)

Oncology Institute (DFPH) has 4 years of Long-Term Investments data on file, last reported at $58.9 million in Q2 2023.

• For the quarter ending Q2 2023, Long-Term Investments changed N/A year-over-year to $58.9 million; the trailing twelve-month figure through Jun 2023 stood at $58.9 million (changed N/A YoY), and the FY2022 full-year result was $58.4 million, changed N/A from the prior year.
• Long-Term Investments for Q2 2023 stood at $58.9 million, roughly flat from $58.8 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $230.3 million in Q1 2021 and bottomed at $58.2 million in Q3 2022.
• The 4-year median for Long-Term Investments is $230.0 million (2021), against an average of $161.5 million.
• The widest annual swing landed in 2021, when Long-Term Investments declined 0.05%; it then plunged 74.69% in 2022.
• A 4-year view of Long-Term Investments shows it stood at $230.3 million in 2020, then slipped by 0.1% to $230.0 million in 2021, then slumped by 74.63% to $58.4 million in 2022, then advanced by 1.01% to $58.9 million in 2023.
• The last three Long-Term Investments figures came in at $58.9 million (Q2 2023), $58.8 million (Q1 2023), and $58.4 million (Q4 2022), per Business Quant data.

Peer Comparison